Skip to main content

Advertisement

Log in

Clinical benefits and risk analysis of topical hemostats: a review

  • REVIEW
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

A variety of local hemostats including absorbable gelatin sponge, collagen hemostat, and oxidized cellulose are commercially available. Local hemostats are applied when cautery, ligature, or other conventional hemostatic method is impractical. Proper handling is essential to control bleeding and only the required amount should be used, even though the hemostat is expected to dissolve promptly. A dry local hemostat absorbs body fluid of several times its own weight and expands postoperatively. Therefore, when an absorbable hemostatic agent is retained on or near bony or neural spaces, the minimum amount should be left after hemostasis is achieved. Documentation is important with regard to the hemostat used, including the name of the agent, site, and amount. This information is used as a reference in the interpretation of postoperative diagnostic images, since retained hemostat may sometimes mimic an abscess or recurrent tumor. The antigenicity of collagen is known to be low because of homology. When the safety of collagen was evaluated, the incidence of positive reactions was reported as 3.0%, and collagen may cause allergic reactions. Minimum inflammation without strong foreign body reactions or blockade of healing is desirable after the use of local hemostats. Strong foreign body reactions, chronic inflammation, and infections can cause granuloma formation after local hemostat use. By using local hemostats, it is possible to improve the condition of the patient, reduce complications, and lower direct and indirect costs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E Gray (1915) ArticleTitleFibrin as a hemostatic in cerebral surgery Surg Gynecol Obstet 21 452–454

    Google Scholar 

  2. S Harvey (1916) ArticleTitleThe use of fibrin paper and foams in surgery Boston Med Surg 174 658–659

    Google Scholar 

  3. V Frantz (1943) ArticleTitleAbsorbable cotton, paper and gauze (oxidized cellulose) Ann Surg 118 116–126

    Google Scholar 

  4. J Correll E Wise (1945) ArticleTitleCertain properties of a new physiologically absorbable sponge Proc Soc Exp Bio Med 58 233–235

    Google Scholar 

  5. T Natsume N Okumura Y Shimizu (1993) ArticleTitleA cotton-like fibrous collagen hemostatic agent Jpn J Artif Organs 22 348–352

    Google Scholar 

  6. T Miyata T Taira Y Noishiki (1992) ArticleTitleCollagen engineering for biomaterial use Clin Mater 9 139–148

    Google Scholar 

  7. Y Tomizawa M Komori K Takada H Nishida M Endo H Kurosawa (2002) ArticleTitleConditions to accelerate vessel formation in wound healing J Jpn Coron Assoc 8 38–40

    Google Scholar 

  8. Y Tomizawa M Komori K Takada H Nishida M Endo H Kurosawa (2003) ArticleTitleIn vivo evaluation of collagen hemostats: biocompatibility and resorption Jpn J Cardiovasc Surg 32 17–22

    Google Scholar 

  9. R Timpl (1984) Immunology of the collagens K Piez A Reddi (Eds) Extracellular matrix biochemistry Elsevier New York 159–190

    Google Scholar 

  10. K Stenzel T Miyata A Rubin (1974) ArticleTitleCollagen as a biomaterial Annu Rev Biophys Bioeng 3 231–253

    Google Scholar 

  11. F DeLustro RA Condell MA Nguyen JM McPherson (1986) ArticleTitleA comparative study of the biologic and immunologic response to medical devices derived from dermal collagen J Biomed Mater Res 20 109–120

    Google Scholar 

  12. LS Cooperman V Mackinnon G Bechler BB Pharriss (1985) ArticleTitleInjectable collagen: a six-year clinical investigation Aesthetic Plast Surg 9 145–151

    Google Scholar 

  13. InstitutionalAuthorNameThe Canadian Multicenter Hemashield Study Group (1990) ArticleTitleImmunologic response to collagen-impregnated vascular grafts: a randomized prospective study J Vasc Surg 12 741–746

    Google Scholar 

  14. K Kitamura R Yasuoka M Ohara M Shimotsuma A Hagiwara T Yamane T Yamaguchi T Takahashi (1995) ArticleTitleHow safe are the xenogeneic hemostats? Report of a case of severe systemic allergic reaction Surg Today 25 433–435

    Google Scholar 

  15. M Chvapil JA Owen DW DeYoung (1983) ArticleTitleA standardized animal model for evaluation of hemostatic effectiveness of various materials J Trauma 23 1042–1047

    Google Scholar 

  16. ME Silverstein K Keown JA Owen M Chvapil (1980) ArticleTitleCollagen fibers as a fleece hemostatic agent J Trauma 20 688–694

    Google Scholar 

  17. E Solheim OG Anfinsen H Holmsen E Sudmann (1991) ArticleTitleEffect of local hemostatics on platelet aggregation Eur Surg Res 23 45–50

    Google Scholar 

  18. WR Wagner JM Pachence J Ristich PC Johnson (1996) ArticleTitleComparative in vitro analysis of topical hemostatic agents J Surg Res 66 100–108

    Google Scholar 

  19. WC Chapman SM Wren GS Lebovic M Malawer R Sherman JE Block (2002) ArticleTitleEffective management of bleeding during tumor resection with a collagen-based hemostatic agent Am Surg 68 802–807

    Google Scholar 

  20. C Alpaslan GH Alpaslan T Oygur (1997) ArticleTitleTissue reaction to three subcutaneously implanted local hemostatic agents Br J Oral Maxillofac Surg 35 129–132

    Google Scholar 

  21. RJ Tamargo JI Epstein CS Reinhard M Chasin H Brem (1989) ArticleTitleBrain biocompatibility of a biodegradable, controlled-release polymer in rats J Biomed Mater Res 23 253–266

    Google Scholar 

  22. Y Tomizawa (2004) ArticleTitleIn vitro and in vivo evaluation of the biocompatibility and cytotoxicity of local hemostatic agents Jpn J Cardiovasc Surg 33 382–386

    Google Scholar 

  23. Y Tomizawa M Endo M Kitamura A Shiikawa Y Yagi H Koyanagi (1991) ArticleTitleCoronary artery bypass graft stenosis suspected to be due to hemostatic agents: a case report Kyobu Geka 44 764–766

    Google Scholar 

  24. T Igari F Iwaya T Abe K Hagiwara M Tanji H Satokawa M Watanabe H Midorikawa Y Sato M Kashida T Ono S Hoshino (1990) ArticleTitleA case of foreign body granuloma after aortic valve replacement Kyobu Geka 43 550–552

    Google Scholar 

  25. MF Ibrahim C Aps CP Young (2002) ArticleTitleA foreign body reaction to Surgicel mimicking an abscess following cardiac surgery Eur J Cardiothorac Surg 22 489–490

    Google Scholar 

  26. JL Ibarrola JE Bjorenson BP Austin H Gerstein (1985) ArticleTitleOsseous reactions to three hemostatic agents J Endod 11 75–83

    Google Scholar 

  27. JE Bjorenson HF Grove MG List SuffixSr GC Haasch BP Austin (1986) ArticleTitleEffects of hemostatic agents on the pH of body fluids J Endod 12 289–292

    Google Scholar 

  28. N Magro-Ernica O Magro-Filho I Rangel-Garcia (2003) ArticleTitleHistologic study of use of microfibrillar collagen hemostat in rat dental sockets Braz Dent J 14 12–15

    Google Scholar 

  29. TA Barbolt M Odin M Leger L Kangas (2001) ArticleTitlePre-clinical subdural tissue reaction and absorption study of absorbable hemostatic devices Neurol Res 23 537–542

    Google Scholar 

  30. KJ Smith HG Skelton TL Barrett M Welch J Beard (1996) ArticleTitleHistologic and immunohistochemical features in biopsy sites in which bovine collagen matrix was used for hemostasis J Am Acad Dermatol 34 434–438

    Google Scholar 

  31. JG Green TM Durham (1991) ArticleTitleApplication of INSTAT hemostat in the control of gingival hemorrhage in a patient with thrombocytopenia. A case report Oral Surg Oral Med Oral Pathol 71 27–30

    Google Scholar 

  32. OR Beirne JR Koehler (1996) ArticleTitleSurgical management of patients on warfarin sodium J Oral Maxillofac Surg 54 1115–1118

    Google Scholar 

  33. P Dineen (1976) ArticleTitleAntibacterial activity of oxidized regenerated cellulose Surg Gynecol Obstet 142 481–486

    Google Scholar 

  34. P Dineen (1977) ArticleTitleThe effect of oxidized regenerated cellulose on experimental intravascular infection Surgery 82 576–579

    Google Scholar 

  35. GB Hill (1978) ArticleTitleEnhancement of experimental anaerobic infections by blood, hemoglobin, and hemostatic agents Infect Immun 19 443–449

    Google Scholar 

  36. KS Scher JA Coil SuffixJr (1982) ArticleTitleEffects of oxidized cellulose and microfibrillar collagen on infection Surgery 91 301–304

    Google Scholar 

  37. F Robicsek GD Duncan GV Born HA Wilkinson TN Masters M McClure (1986) ArticleTitleInherent dangers of simultaneous application of microfibrillar collagen hemostat and blood-saving devices J Thorac Cardiovasc Surg 92 766–770

    Google Scholar 

  38. M McClure GD Duncan GV Born F Robicsek (1987) ArticleTitleIn vitro effect of a microfibrillar collagen hemostat on platelets Haemostasis 17 349–352

    Google Scholar 

  39. Y Tomizawa Y Noishiki M Endo A Hashimoto H Koyanagi (1996) ArticleTitleEvaluation of blood absorption, hemostatic ability and purity of a polyepoxy compound cross-linked cotton-type collagen hemostat Kyobu Geka 49 126–129

    Google Scholar 

  40. MD Orr AG Ferdman JG Maresh (1994) ArticleTitleRemoval of Avitene microfibrillar collagen hemostat by use of suitable transfusion filters Ann Thorac Surg 57 1007–1011

    Google Scholar 

  41. G Gondo T Yamashita Y Ishiwata K Hirata M Satoh (1989) ArticleTitlePeculiar computed tomographic images after intracranial use of microfibrillar collagen hemostat: report of three cases No Shinkei Geka 17 1067–1071

    Google Scholar 

  42. GS Sandhu JA Elexpuru-Camiruaga S Buckley (1996) ArticleTitleOxidized cellulose (Surgicel) granulomata mimicking tumour recurrence Br J Neurosurg 10 617–619

    Google Scholar 

  43. KF Kothbauer GI Jallo J Siffert E Jimenez JC Allen FJ Epstein (2001) ArticleTitleForeign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases J Neurosurg 95 503–506

    Google Scholar 

  44. T Ribalta IE McCutcheon AG Neto D Gupta AJ Kumar DA Biddle LA Langford JM Bruner NE Leeds GN Fuller (2004) ArticleTitleTextiloma (gossypiboma) mimicking recurrent intracranial tumor Arch Pathol Lab Med 128 749–758

    Google Scholar 

  45. A Oto EM Remer CM O'Malley JA Tkach IS Gill (1999) ArticleTitleMR characteristics of oxidized cellulose (Surgicel) AJR Am J Roentgenol 172 1481–1484

    Google Scholar 

  46. M Spiller MS Tenner WT Couldwell (2001) ArticleTitleEffect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging J Neurosurg 95 687–693

    Google Scholar 

  47. F Patane E Zingarelli A Verzini M di Summa (2001) ArticleTitleComplication due to excessive use of Surgicel Eur J Cardiothorac Surg 20 1034

    Google Scholar 

  48. F van Gelderen J Swinnen (1996) ArticleTitleAppearance of oxidized cellulose (Surgicel) on abdominal radiographs AJR Am J Roentgenol 167 1593

    Google Scholar 

  49. JW Melamed EK Paulson MA Kliewer (1995) ArticleTitleSonographic appearance of oxidized cellulose (Surgicel): pitfall in the diagnosis of postoperative abscess J Ultrasound Med 14 27–30

    Google Scholar 

  50. ST Young EK Paulson RL McCann ME Baker (1993) ArticleTitleAppearance of oxidized cellulose (Surgicel) on postoperative CT scans: similarity to postoperative abscess Am J Roentgenol 160 275–277

    Google Scholar 

  51. BR Turley RE Taupmann PL Johnson (1994) ArticleTitlePostoperative abscess mimicked by Surgicel Abdom Imaging 19 345–346

    Google Scholar 

  52. AR O'Connor FV Coakley MV Meng S Eberhardt (2003) ArticleTitleImaging of retained surgical sponges in the abdomen and pelvis Am J Roentgenol 180 481–489

    Google Scholar 

  53. VL Schiller P Joyce D Sarti (1994) ArticleTitleHemostatic agent and concomitant abdominal abscess Am J Roentgenol 162 236

    Google Scholar 

  54. S Iwabuchi K Koike T Okabe S Tago T Murakami (1997) ArticleTitleIatrogenic paraplegia caused by Surgicel used for hemostasis during a thoracotomy: report of a case Surg Today 27 969–970

    Google Scholar 

  55. AR Brodbelt JB Miles PM Foy JC Broome (2002) ArticleTitleIntraspinal oxidized cellulose (Surgicel) causing delayed paraplegia after thoracotomy – a report of three cases Ann R Coll Surg Engl 84 97–99

    Google Scholar 

  56. RZ Lovstad PA Steen M Forsman (1999) ArticleTitleParaplegia after thoracotomy – not caused by the epidural catheter Acta Anaesthesiol Scand 43 230–232

    Google Scholar 

  57. EE Awwad KR Smith SuffixJr (1999) ArticleTitleMRI of marked dural sac compression by Surgicel in the immediately postoperative period after uncomplicated lumbar laminectomy J Comput Assist Tomogr 23 969–975

    Google Scholar 

  58. DH Alander ES Stauffer (1995) ArticleTitleGelfoam-induced acute quadriparesis after cervical decompression and fusion Spine 20 970–971

    Google Scholar 

  59. J Friedman TS Whitecloud SuffixIII (2001) ArticleTitleLumbar cauda equina syndrome associated with the use of Gelfoam: case report Spine 26 E485–E487

    Google Scholar 

  60. FDA Public Health Notification: Paralysis from absorbable hemostatic agent. Feb 4, 2004. http://www.fda.gov/cdrh/safety/040204-hemostatics.html

  61. JJ Dutton DT Tse RL Anderson (1983) ArticleTitleCompressive optic neuropathy following use of intracranial oxidized cellulose hemostat Ophthalmic Surg 14 487–490

    Google Scholar 

  62. T Nakayama K Shimazaki J Ono K Ohsato A Yamaura (1994) ArticleTitleIntracranial foreign body granuloma caused by fine cotton fibers: a case report No Shinkei Geka 22 1081–1084

    Google Scholar 

  63. H Ito H Onishi K Shoin H Nagatani (1989) ArticleTitleGranuloma caused by oxidized cellulose following craniotomy Acta Neurochir (Wien) 100 70–73

    Google Scholar 

  64. M Nakajima T Kamei K Tomimatu T Manabe (1995) ArticleTitleAn intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene) Arch Pathol Lab Med 119 1161–1163

    Google Scholar 

  65. DH McGregor RI MacArthur T Carter (1986) ArticleTitleAvitene granulomas of colonic serosa Ann Clin Lab Sci 16 296–302

    Google Scholar 

  66. AF Chung J Menon TF Dillon (1978) ArticleTitleAcute postoperative retroperitoneal fibrosis and ureteral obstruction secondary to the use of Avitene Am J Obstet Gynecol 132 908–909

    Google Scholar 

  67. BL Erstad (2001) ArticleTitleAntifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery Ann Pharmacother 35 1075–1084

    Google Scholar 

  68. DE Harmon (1996) ArticleTitleCost/benefit analysis of pharmacologic hemostasis Ann Thorac Surg 61 S21–S25

    Google Scholar 

  69. MC Oz DM Cosgrove SuffixIII BR Badduke JD Hill MR Flannery R Palumbo N Topic (2000) ArticleTitleThe Fusion Matrix Study Group. Controlled clinical trial of a novel hemostatic agent in cardiac surgery Ann Thorac Surg 69 1376–1382

    Google Scholar 

  70. RJ Fischel RJ McKenna SuffixJr (1998) ArticleTitleBovine pericardium versus bovine collagen to buttress staples for lung reduction operations Ann Thorac Surg 65 217–219

    Google Scholar 

  71. M Sirlak S Eryilmaz L Yazicioglu U Kiziltepe Z Eyileten MS Durdu R Tasoz NT Eren A Aral B Kaya H Akalin (2003) ArticleTitleComparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery J Thorac Cardiovasc Surg 126 666–670

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuko Tomizawa MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomizawa, Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs 8, 137–142 (2005). https://doi.org/10.1007/s10047-005-0296-x

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-005-0296-x

Key words

Navigation